Darolutamide - Uses, Dosage, Side Effects, Drug Warnings, and Precautions

What Is the Use of Darolutamide?

Darolutamide is a drug used for the treatment of prostate cancer. The drug is prescribed in cases where the tumor progresses, even though testosterone levels have been lowered. Such cancer is known as castration-resistant prostate cancer (CRPC).

Darolutamide is used in the treatment of the following:

• Non-metastatic CRPC (tumor has not metastasized).

• Metastatic hormone-sensitive prostate cancer (tumor has metastasized but is sensitive to hormonal treatment).

Studies demonstrate the effectiveness of Darolutamide in inhibiting the progression of cancer cells.

FDA Approvals

The US FDA (Food and Drug Administration) has granted multiple approvals for the use of Darolutamide in the treatment of prostate cancer at various stages.

• The first approval was granted for the use of Darolutamide for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC) on July 30, 2019. It is used when the cancer is not metastatic but does not respond to hormonal therapies.

• On August 5, 2022, the second approval was granted for the use of Darolutamide in combination with Docetaxel. It was for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC).

• Finally, an approval was granted for the use of Darolutamide for the treatment of metastatic castration-sensitive prostate cancer (mCSPC) along with androgen deprivation therapy (ADT) on June 3, 2025. This approval was made possible by the ARANOTE study's positive results, which showed improvement in radiographic progression-free survival (rPFS).

How Does Darolutamide Work?

Darolutamide blocks androgen receptors in prostate cancer cells. This prevents male hormones, such as testosterone and dihydrotestosterone (DHT), from binding to these receptors.

Because of this:

• Cancer cells grow more slowly.

• Tumor progression is delayed.

It could, therefore, be summed up that Darolutamide in advanced prostate cancer is used to control the development of cancer by preventing the signaling of cell multiplication. Darolutamide has low brain penetration, which may reduce some nervous system side effects.

Drug Group:

Darolutamide is an androgen receptor inhibitor and an antineoplastic agent. Antineoplastic agents are medications that inhibit cancer cell proliferation by preventing hormonal stimulation.

• Dosage: 300 mg (milligrams) tablet.

• Form: Oral tablet.

• Method of Administration: Oral.

For Patients:

For Which Disease Is Darolutamide Prescribed?

Conditions treated by Darolutamide include:

• Non-metastatic castration-resistant prostate cancer, i.e., prostate cancer that has not spread but is hormone-resistant.

• Metastatic hormone-sensitive prostate cancer, i.e., prostate cancer that has spread but remains hormone-sensitive.

Darolutamide may be administered if the prostate cancer progresses despite the administration of hormones. The use of the medication depends on the stage of the cancer and the patient's overall health.

How Effective Is Darolutamide?

It has been shown that the use of Darolutamide could play an important role in delaying the metastasization process of prostate cancer cells in the body of the patient. In essence, this translates into prolonged metastasis-free survival for patients who are using this drug.

Nevertheless, the outcomes of the drug usage could be different for each case. Possible factors affecting its efficiency could include the stage of cancer development and the patient's general health, among others.

What Should You Tell Your Doctor Before Starting Darolutamide Therapy?

Prior to beginning Darolutamide treatment, discuss your full medical history with your physician in order to ensure that the drug is prescribed safely.

• Medication History: Your physician needs to be informed of any previous conditions, surgical procedures, allergies, or other medications you are taking.

• Liver Conditions: The functioning of your liver might be affected by Darolutamide. It might be necessary to undergo certain blood tests before and during treatment with Darolutamide.

• Seizure History: If you have ever suffered from seizures or have had any other illness connected with your brain, inform your physician about it.

• Interactions With Other Medications: It is important to notify your physician about all the medicines, supplements, or vitamins that you take to avoid adverse interactions with Darolutamide.

• Risk of Pregnancy: This medication may cause harm to the fetus; therefore, effective contraception is required while being on Darolutamide and after it is stopped.

How Is Darolutamide Administered?

Darolutamide must be taken as prescribed by the physician.

Dosage:

• 600 mg in each dose.

• Two 300 mg tablets per day.

• Consume the medicine along with food.

Dosing Guidelines:

• Consume tablets whole with water.

• Crushing or chewing tablets is strictly prohibited.

• Take the medicine regularly.

What Are the Darolutamide Side Effects?

Similar to other drugs, Darolutamide might produce some adverse reactions. According to clinical trials, these are some of the adverse reactions that have been observed:

• Fatigue: A state of feeling tired.

• Muscle or Joint Pains: Pains experienced within the muscles or joints of the body.

• Headaches.

• Hypertension: High blood pressure.

• Rash: Skin irritation.

• Increased risk of falls.

These are just some of the common adverse reactions experienced by patients taking Darolutamide.

Dietary Advice

Maintain a balanced diet during therapy.

Suggestions:

• Consume adequate amounts of water.

• Consume foods that are high in protein.

• Eat fruits and vegetables.

• Reduce your alcohol consumption.

Missed Dosage

In case of a missed dose, the user should take it as soon as they remember. However, when the missed dose time is almost equal to the next one, it is best to skip it. Users should avoid taking two doses to make up for a missed dose, as this can increase the risk of side effects.

Overdosage

Overdose occurs when a user takes too much of Darolutamide. This can result in symptoms like fatigue or weakness, among others.

Storage

The recommended temperature for storing Darolutamide tablets is 20°C (degrees Celsius) to 25°C. The medicine should be stored in its original packaging and kept away from heat, humidity, and direct sunlight. The medicine should be stored in an airtight container. It should be stored out of reach of children.

For Doctors

Darolutamide is a prescription oral drug used to treat advanced prostate cancer. The treatment is used in:

• Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC).

• Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).

Contraindications

Darolutamide must not be administered to individuals who are hypersensitive to Darolutamide or any of its ingredients. Darolutamide must not be taken when pregnant or nursing because of possible damage to the child.

Administration and Dosage

The recommended dosage is 600 mg, administered twice daily orally with meals. The dose can be adjusted based on the patient’s tolerance and any possible side effects. Patients with moderate liver damage and severe renal insufficiency should exercise special care. Treatment should be stopped if there is severe drug toxicity or intolerance.

Pharmacokinetics

• Absorption: Darolutamide gets absorbed after oral administration. The maximum drug concentration occurs around four hours post-dose.

• Metabolism: It is primarily metabolized in the liver by CYP3A4.

• Excretion: This drug is primarily eliminated in feces, with minimal excretion in urine.

• Half-life: 15 hours.

• Steady State: Attained within a couple of days from regular consumption.

Toxicity

• Carcinogenicity: Few studies have examined the carcinogenicity of Darolutamide over the long term. There are not many of them.

• Mutagenicity: No significant mutagenic risk has been observed in non-clinical studies.

• Fertility Impairment: Studies in animals indicate a possible risk for reproductive toxicity.

What Are the Warnings of Darolutamide?

• Effects on the Liver: Darolutamide can alter liver function. Regular testing is necessary to assess liver function during treatment.

• Effects on the Brain: The use of Darolutamide requires caution among people with a history of convulsions or brain disorders.

• Risk During Pregnancy: Taking Darolutamide is likely to affect the health of the unborn child. It is recommended to practice effective contraception during treatment and after.

• Use in Children: Darolutamide has not been studied in pediatric patients.

• Allergic Reaction: If you develop any allergic reactions, including rashes, swelling, or difficulty breathing, contact your healthcare provider immediately.

• Risk of Convulsions: Patients with a history of convulsions need to be under constant supervision when taking Darolutamide.

What Are the Drug Interactions of Darolutamide?

There can be drug interactions with Darolutamide, which might reduce the effectiveness of the drug or increase the chance of adverse reactions.

Drugs that could decrease the effectiveness of the medication include:

• Rifampin.

• Carbamazepine.

• Phenytoin.

• St. John’s wort.

Drugs that could cause adverse effects to worsen include:

• Ketoconazole.

• Clarithromycin.

• Ritonavir.

Anticoagulants: Drugs like Warfarin might increase bleeding risks if used in combination with Darolutamide.

Special Considerations:

• Pregnancy and Contraceptive Methods: The drug may pose a risk to the fetus if taken by a woman who is pregnant. Appropriate measures should be undertaken to prevent pregnancy for up to seven days after the final dose of the medication.

• Lactation: The medication can be excreted into breast milk and affect the child. It is not recommended to breastfeed while on Darolutamide.

• Operating Machinery and Driving: Some individuals may experience dizziness or tiredness after taking this medication.

Conclusion:

Darolutamide is a type of drug prescribed for treating some forms of prostate cancer. It blocks the action of male hormones such as testosterone, which support the growth of cancer cells. The drug Darolutamide can be used alone or in combination with others based on the severity and state of cancer. Visit your doctor regularly for proper monitoring and management of potential side effects. Please feel free to contact our cancer specialist for more information on Darolutamide.

Key Takeaways:

• Darolutamide is an oral medication that can be used for treating prostate cancer.

• Darolutamide acts by blocking the action of male hormones on cancer cells' receptors. As a result, it inhibits the development of cancer and its metastasis.

• The normal dosage should be administered twice daily with food intake.

• Frequent medical checkups will be required during therapy.